| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ccd3799a0f6285fa42baaedb6cd9dda4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_57adbd7921f6f39d629658ecb09f0bef |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-723 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5308
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57496 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate |
2014-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6c78e5963109d55e0e1df1c125960b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6d3ac69d7a70e48db23356c561196db |
| publicationDate |
2014-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014363425-A1 |
| titleOfInvention |
Systems and methods for identifying cancers having activated progesterone receptors |
| abstract |
Systems and methods for identifying tumors having activated progesterone receptors are provided. Patients suspected of having a tumor susceptible to growth inhibition by anti-progestins can be treated with an anti-progestin. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3822368-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11672762-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113456631-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020500198-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10548905-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10308676-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021094430-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10786461-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015136355-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11613555-B2 |
| priorityDate |
2013-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |